Related Experiment Video

Updated: May 27, 2026

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

miR-15a and miR-16-1 inhibit the proliferation of leukemic cells by down-regulating WT1 protein level

Shen-meng Gao1, Chong-yun Xing, Chi-qi Chen

  • 1Laboratory of Internal Medicine, The First Affiliated Hospital of Wenzhou Medical College, China.

Journal of Experimental & Clinical Cancer Research : CR
|December 3, 2011
PubMed
Abstract

Insights

MicroRNAs miR-15a/16-1 suppress leukemia cell growth by reducing WT1 protein, but not mRNA. This suggests a tumor suppressor role for miR-15a/16-1 in leukemia, though the exact mechanism requires further investigation.

Area of Science:

  • Molecular Biology
  • Oncology
  • Gene Regulation

Background:

  • MicroRNAs miR-15a and miR-16-1 are recognized as tumor suppressors in various leukemias.
  • The precise mechanism by which these microRNAs inhibit leukemic cell proliferation remains unclear.

Purpose of the Study:

  • To investigate the role of miR-15a/16-1 in regulating the proliferation of K562 and HL-60 leukemic cells.
  • To explore the potential involvement of the WT1 oncogene in the tumor-suppressive function of miR-15a/16-1.

Main Methods:

  • Overexpression of miR-15a/16-1 in K562 and HL-60 cells.
  • Assessment of cell proliferation using CCK-8 assays and direct cell counts.
  • Measurement of WT1 protein and mRNA levels via Western blotting and quantitative real-time PCR.
  • Luciferase reporter assays to assess WT1 3'-UTR activity.
  • Silencing of WT1 using siRNA and assessment of proliferation.
  • Inhibition of miR-15a/16-1 using anti-miR oligonucleotides (AMO).

Main Results:

  • Overexpression of miR-15a/16-1 significantly inhibited the proliferation of K562 and HL-60 cells.
  • miR-15a/16-1 overexpression reduced WT1 protein levels but did not affect WT1 mRNA levels.
  • WT1 3'-UTR activity was not directly inhibited by miR-15a/16-1.
  • Silencing WT1 mimicked the anti-proliferative effect of miR-15a/16-1.
  • AMOs reversed WT1 expression changes.
  • An inverse correlation between miR-15a/16-1 expression and WT1 protein levels was observed in primary AML blasts.

Conclusions:

  • miR-15a/16-1 likely acts as a tumor suppressor in leukemic cells by downregulating WT1.
  • The downregulation of WT1 by miR-15a/16-1 appears to be post-transcriptional and not mediated by direct miRNA-mRNA base pairing.
  • Further research is needed to elucidate the precise mechanism of miR-15a/16-1-mediated WT1 regulation.

More Related Videos

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...